Brigitte Landesmann

2.1k total citations · 1 hit paper
21 papers, 1.5k citations indexed

About

Brigitte Landesmann is a scholar working on Computational Theory and Mathematics, Small Animals and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Brigitte Landesmann has authored 21 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Computational Theory and Mathematics, 5 papers in Small Animals and 4 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Brigitte Landesmann's work include Computational Drug Discovery Methods (8 papers), Animal testing and alternatives (5 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Brigitte Landesmann is often cited by papers focused on Computational Drug Discovery Methods (8 papers), Animal testing and alternatives (5 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Brigitte Landesmann collaborates with scholars based in Italy, United States and United Kingdom. Brigitte Landesmann's co-authors include Maurice Whelan, Sharon Munn, Daniel L. Villeneuve, Teresa Lettieri, Mary Ann Ottinger, Markus Hecker, Doug Crump, Natàlia García‐Reyero, Lucia Vergauwen and Carlie A. LaLone and has published in prestigious journals such as PLoS ONE, Drug Discovery Today and Toxicological Sciences.

In The Last Decade

Brigitte Landesmann

20 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adverse Outcome Pathway (AOP) Development I: Strategies and Principles

2014 488 citations Daniel L. Villeneuve, Doug Crump et al. Toxicological Sciences profile →

Peers

Countries citing papers authored by Brigitte Landesmann

Since Specialization

Citations

This map shows the geographic impact of Brigitte Landesmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brigitte Landesmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brigitte Landesmann more than expected).

Fields of papers citing papers by Brigitte Landesmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brigitte Landesmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brigitte Landesmann. The network helps show where Brigitte Landesmann may publish in the future.

Co-authorship network of co-authors of Brigitte Landesmann

This figure shows the co-authorship network connecting the top 25 collaborators of Brigitte Landesmann. A scholar is included among the top collaborators of Brigitte Landesmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brigitte Landesmann. Brigitte Landesmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mechanistic Understanding of the Olfactory Neuroepithelium Involvement Leading to Short-Term Anosmia in COVID-19 Using the Adverse Outcome Pathway Framework 2022 ·Cells ·(unknown), F Bernardi, (unknown), Magdalini Sachana, Laure‐Alix Clerbaux, Amalia Muñoz, (unknown), Brigitte Landesmann, Katja M. Kanninen, Sandra Coecke	12
2	Factors Modulating COVID-19: A Mechanistic Understanding Based on the Adverse Outcome Pathway Framework 2022 ·Journal of Clinical Medicine ·Laure‐Alix Clerbaux, Maria Cristina Albertini, Núria Amigó, Anna Beronius, Gillina F. G. Bezemer, Sandra Coecke, Evangelos P. Daskalopoulos, Giusy del Giudice, Dario Greco, Lucia Grenga, Alberto Mantovani, Amalia Muñoz, Elma Omeragić, Nikolaos Parissis, Mauro Petrillo, Laura Aliisa Saarimäki, Helena Soares, Kristie Sullivan, Brigitte Landesmann	20
3	Systematic Organization of COVID-19 Data Supported by the Adverse Outcome Pathway Framework 2021 ·Frontiers in Public Health ·Penny Nymark, Magdalini Sachana, Sofia Batista Leite, Jukka Sund, Catharine E. Krebs, Kristie Sullivan, Stephen W. Edwards, (unknown), Catherine Willett, Brigitte Landesmann, Clemens Wittwehr	20
4	Representing the Process of Inflammation as Key Events in Adverse Outcome Pathways 2018 ·Toxicological Sciences ·Daniel L. Villeneuve, Brigitte Landesmann, Paola Allavena, Noah T. Ashley, Anna Bal‐Price, Emanuela Corsini, Sabina Halappanavar, Tracy Hussell, Debra L. Laskin, Toby Lawrence, David J. Nikolic‐Paterson, Marc Pallardy, Alicia Paini, Raymond Pieters, Robert A. Roth, (unknown)	46
5	Towards a 21st-century roadmap for biomedical research and drug discovery: consensus report and recommendations 2016 ·Drug Discovery Today ·(unknown), Ian M. Adcock, François Busquet, Kevin M. Crofton, (unknown), Christoph Giese, Tuula Heinonen, Kathrin Herrmann, Martin Hofmann‐Apitius, Brigitte Landesmann, Lindsay J. Marshall, (unknown), Alysson R. Muotri, Noor Fatima, Katrin Schütte, Troy Seidle, Anja van de Stolpe, Hilde Van Esch, Catherine Willett, Grzegorz Woszczek	60
6	Adverse outcome pathway development from protein alkylation to liver fibrosis 2016 ·Archives of Toxicology ·Tomislav Horvat, Brigitte Landesmann, Alfonso Lostia, Mathieu Vinken, Sharon Munn, Maurice Whelan	35
7	How Adverse Outcome Pathways Can Aid the Development and Use of Computational Prediction Models for Regulatory Toxicology 2016 ·Toxicological Sciences ·Clemens Wittwehr, Hristo Aladjov, Gerald T. Ankley, Hugh J. Byrne, Joop de Knecht, Elmar Heinzle, Günter Klambauer, Brigitte Landesmann, Mirjam Luijten, Cameron MacKay, Gavin Maxwell, M.E. Meek, Alicia Paini, Edward J. Perkins, Tomasz Sobański, (unknown), Katrina M. Waters, Maurice Whelan	119
8	The Adverse Outcome Pathway approach in nanotoxicology 2016 ·Computational Toxicology ·Kirsten Gerloff, Brigitte Landesmann, Andrew Worth, Sharon Munn, Taina Palosaari, Maurice Whelan	79
9	Putative adverse outcome pathways relevant to neurotoxicity 2015 ·Critical Reviews in Toxicology ·Anna Bal‐Price, Kevin M. Crofton, Magdalini Sachana, Timothy J. Shafer, Mamta Behl, Anna Forsby, Alan J. Hargreaves, Brigitte Landesmann, Pamela J. Lein, Jochem Louisse, Florianne Monnet‐Tschudi, Alicia Paini, Alexandra Rolaki, André Schrattenholz, Cristina Suñol, Christoph van Thriel, Maurice Whelan, Ellen Fritsche	82
10	Sex Differences in Liver Toxicity—Do Female and Male Human Primary Hepatocytes React Differently to Toxicants In Vitro? 2015 ·PLoS ONE ·Milena Mennecozzi, Brigitte Landesmann, Taina Palosaari, (unknown), Maurice Whelan	57
11	Using AOPs to transition to alternative approaches to predict toxicity 2015 ·Toxicology Letters ·Sharon Munn, Brigitte Landesmann, (unknown), Alivia Lee Price, Alexandra Rolaki, Magdalini Sachana, Clemens Wittwehr, Maurice Whelan	1
12	Adverse Outcome Pathways Knowledge Base (AOP-KB) 2015 ·Toxicology Letters ·Clemens Wittwehr, Sharon Munn, Brigitte Landesmann, Maurice Whelan	2
13	Adverse Outcome Pathway (AOP) Development I: Strategies and Principles breakdown → 2014 ·Toxicological Sciences ·Daniel L. Villeneuve, Doug Crump, Natàlia García‐Reyero, Markus Hecker, Thomas H. Hutchinson, Carlie A. LaLone, Brigitte Landesmann, Teresa Lettieri, Sharon Munn, (unknown), Mary Ann Ottinger, Lucia Vergauwen, Maurice Whelan	488
14	Adverse Outcome Pathway Development II: Best Practices 2014 ·Toxicological Sciences ·Daniel L. Villeneuve, Doug Crump, Natàlia García‐Reyero, Markus Hecker, Thomas H. Hutchinson, Carlie A. LaLone, Brigitte Landesmann, Teresa Lettieri, Sharon Munn, (unknown), Mary Ann Ottinger, Lucia Vergauwen, Maurice Whelan	180
15	SEURAT-1 liver gold reference compounds: a mechanism-based review 2014 ·Archives of Toxicology ·Paul Jennings, Michael Schwarz, Brigitte Landesmann, Silvia Maggioni, Μαρίνα Γούμενου, (unknown), Martin O. Leonard, Jeffrey S. Wiseman	24
16	Mode-of-action working group: capturing mode-of-action knowledge 2014 ·VUBIR (Vrije Universiteit Brussel) ·Brigitte Landesmann, Mathieu Vinken	0
17	Development of an Adverse Outcome Pathway From Drug-Mediated Bile Salt Export Pump Inhibition to Cholestatic Liver Injury 2013 ·Toxicological Sciences ·Mathieu Vinken, Brigitte Landesmann, Μαρίνα Γούμενου, (unknown), Imran Shah, Hartmut Jaeschke, Catherine Willett, Maurice Whelan, Vera Rogiers	96
18	Adverse Outcome Pathway-based Screening Strategies for an Animal-free Safety Assessment of Chemicals 2013 ·Alternatives to Laboratory Animals ·Brigitte Landesmann, Milena Mennecozzi, Elisabet Berggren, Maurice Whelan	14
19	High content hepatotoxicity screening based on mode-of-action approach 2012 ·Toxicology Letters ·Milena Mennecozzi, Georgina Harris, (unknown), Brigitte Landesmann, Roman Liška, Maurice Whelan	3
20	Description of Prototype Modes-of-Action Related to Repeated Dose Toxicity 2012 ·Joint Research Centre (European Commission) ·Brigitte Landesmann, (unknown), (unknown), (unknown)	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact